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a b s t r a c t
The immediate early (IE) 62 protein is the major varicella-zoster virus (VZV) regulatory factor. Analysis of
the VZV genome revealed 40 predicted GC-rich boxes within 36 promoters. We examined effects of
ectopic expression of Sp1-Sp4 on IE62- mediated transactivation of three viral promoters. Ectopic
expression of Sp3 and Sp4 enhanced IE62 activation of ORF3 and gI promoters while Sp3 reduced IE62
activation of ORF28/29 promoter and VZV DNA replication. Sp2 reduced IE62 transactivation of gI while
Sp1 had no signiﬁcant inﬂuence on IE62 activation with any of these viral promoters. Electrophoretic
mobility shift assays (EMSA) conﬁrmed binding of Sp1 and Sp3 but not Sp2 and Sp4 to the gI promoter.
Sp1–4 bound to IE62 and amino acids 238–258 of IE62 were important for the interaction with Sp3 and
Sp4 as well as Sp1. This work shows that Sp family members have differential effects on IE62-mediated
transactivation in a promoter-dependent manner.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Varicella-zoster virus (VZV) is an alphaherpesvirus that causes two
diseases, varicella or chickenpox during primary infection and herpes
zoster or shingles upon reactivation from latency. It has a 125 kb linear
double-stranded DNA genome that encodes at least 71 genes (Arvin
and Gilden, 2013). VZV gene expression during lytic infection is
thought to occur in three kinetic stages, immediate early (IE), early
and late. VZV utilizes the host cell RNA polymerase II (RNA Pol II) and
the general transcription machinery of the cell for viral gene tran-
scription as do the other herpesviruses. A few VZV regulatory proteins,
including IE62, IE4, ORF61, IE63 and ORF10 are responsible for efﬁcient
viral gene expression (Arvin and Gilden, 2013).
IE62, a tegument protein, is the major VZV transactivator,
regulates the expression from all of the VZV promoters tested to
date (Kinchington et al., 2000; Arvin and Gilden, 2013) and also
activates a variety of cellular promoters (Perera, 2000). It is a 1310
amino acid protein with ﬁve distinct domains, based on compar-
isons with other herpesvirus IE transactivators (Cheung, 1989). Of
these domains, II and IV are the most conserved at the amino acid
level, while domain I, III and V show signiﬁcant variability. Among
the functions mapped to the various domains of IE62, domain I (aa
1–467) contains an acidic activation domain essential for the
transcription activation function of IE62. Domain II (aa468–640)
contains a highly conserved DNA binding and dimerization
domain. These two domains have been shown to be a platform
for the physical interaction of IE62 with several cellular transcrip-
tion factors and VZV proteins. The VZV proteins ORF9 and IE4 bind
to the acidic activation domain (Cilloniz et al., 2007; Spengler
et al., 2000) while IE63 interacts with the DNA binding and
dimerization domain (Lynch et al., 2002). The cellular TATA box
binding protein (TBP) also interacts with the DNA binding domain
while the cellular transcription factors USF and Sp1 bind to the
acidic activation domain (Peng et al., 2003; Rahaus et al., 2003).
The Sp/KLF family contains at least twenty members identiﬁed
thus far, with the prototypes being Sp1, Sp2, Sp3 and Sp4.
Members of this family bind with varying afﬁnities to sequences
designated as ‘Sp1 sites’ (e.g., GC-boxes and CACCC-boxes). Sp
family proteins are characterized by a highly conserved C-terminal
DNA-binding domain containing three zinc ﬁngers (Philipsen and
Suske, 1999). Although conservation within their DNA binding
domains means that Sp1-related proteins can interact with the
same DNA sequences, the family members vary in their interaction
with different sequences. For example, Sp1, Sp3, and Sp4 bind with
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higher afﬁnity to GC-boxes than to CACCC-boxes (Hagen et al.,
1992; Hagen et al., 1995; Kingsley and Winoto, 1992; Thiesen and
Bach, 1990), whereas Sp2 binds preferentially to CACCC-boxes over
GC-boxes (Crossley et al., 1996; Matsumoto et al., 1998; Shields
and Yang, 1998). While Sp1, Sp2 and Sp3 are ubiquitously
expressed in different tissues, Sp4 is expressed primarily in
neurons and cells of neuronal origin.
Sp1 binds to several VZV promoters (Peng et al., 2003;
Ruyechan et al., 2003). The GC rich sequence that binds Sp1 has
been found in the promoters of VZV ORF61, viral glycoproteins gI
and gE, the VZV major single-strand binding protein and the VZV
DNA polymerase catalytic subunit (Wang et al., 2009; Berarducci
et al., 2007; Peng et al., 2003; Yang et al., 2004). Recently we
reported that Sp3, in addition to Sp1, binds to the downstream
region of VZV oriS and to the ORF3 promoter. Mutation of their
binding sites reduced ORF62, ORF63 and ORF3 expression in
reporter gene assays (Khalil et al., 2012, 2013). The contributions
of Sp2 and Sp4 to VZV gene expression and replication remain
unknown. The binding of Sp3 to the Sp1 binding sites in some VZV
promoters, raised a speciﬁc question; is the involvement of these
GC-rich sequences in IE62-mediated transactivation due to the
binding of Sp3 rather than or in concert with Sp1?
In the work presented here, we extend our study of the role of
Sp family members in VZV replication by examining the inﬂuence
of the ectopic expression of four Sp family members, Sp1, 2, 3 and
4, on IE62 regulation of viral promoters that we showed previously
to contain functional Sp1 sites. We demonstrate that Sp3 increases
IE62-mediated transactivation of ORF3 and gI promoters as well as
the model luciferase reporter pSp1-TA-Luc, while it reduces IE62
activation of the ORF28/29 promoter. In contrast, Sp2 reduced
IE62-mediated transactivation of model promoters and the gI
promoter, a ﬁnding consistent with the inhibitory effects typical
of Sp2. Surprisingly, the ectopic expression of Sp1 had no effect on
IE62-mediated transactivation of any of the VZV promoters or
model promoters. Of particular interest, the ectopic expression of
Sp3, which inhibited the dual ORF28/29 promoters, also inhibited
oriS dependent DNA replication in DpnI assays. This work suggests
that the Sp family members have signiﬁcant differential effects on
IE62-mediated activation of VZV genes and, contrary to previous
hypotheses, Sp3 may play a much more important role than Sp1.
Results
Predicted Sp1 binding sites within putative VZV promoters
The number of predicted Sp1 binding sites in putative VZV
promoters was determined using the two Sp1 binding sites
previously identiﬁed in the VZV ORF3 and gI promoters as the
template for a bioinformatics search. These were 50–CCCGCCC-30 in
the ORF3 promoter and 50–CACGCCCC-30 in the gI promoter (Peng
et al., 2003; Khalil et al., 2013). The search was done with NCBI
Blastn program (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and a con-
servative promoter size of 200–300 bp upstream from the transla-
tional start sites of the VZV genes was chosen. Forty Sp1 sites were
identiﬁed within putative promoter regions (Table 1). Of the 36
promoters identiﬁed, we chose three that we had studied pre-
viously, (ORF3, ORF28/29 and gI), to assess how over-expression of
Sp family members affected VZV genes transcription.
Ectopic expression of Sp family members inﬂuences IE62-mediated
transactivation differentially in a promoter dependent manner
In the ﬁrst set of experiments, reporter gene assays were done
in the context of pCMV-62 transfection in the presence and
absence of plasmids expressing Sp1, Sp2, Sp3 and Sp4, using two
reporters containing model promoters. One model reporter, pTA-
Luc, is a minimal promoter including only a TATA element. The
second model reporter contains the Sp1 site identiﬁed in the
downstream region of VZV oriS (Khalil et al., 2008) at a distance of
25 nucleotides upstream of the same TATA element (Fig. 1A).
Luciferase activities obtained from each reporter plasmid in the
absence of ORF62, but with ectopic expression of Sp family
members, represented basal activity levels and were normalized
to 1. Reporter gene activities in the presence of ORF62 transfection
and/or plasmids over-expressing Sp1, Sp2, Sp3 and Sp4 were
displayed as induction (n-fold) of luciferase activities relative to
the basal activity.
As shown in Fig. 1B and C, IE62 activated the two model
reporters, as did the Sp family members Sp1, Sp3 and Sp4, but to
a lesser extent. Ectopic expression of Sp2 reduced IE62 activation of
the two reporters signiﬁcantly while Sp1 had no statistically
signiﬁcant inﬂuence. In contrast, Sp3 activated the IE62-mediated
transactivation of pSp1-TA-Luc reporter signiﬁcantly but had no
signiﬁcant effect on IE62 activation of the pTA-Luc reporter. Sp4
overexpression reduced IE62 activation of the pTA-Luc reporter
signiﬁcantly but had no statistically signiﬁcant inﬂuence on IE62-
mediated transactivation of the pSp1-TA-Luc reporter.
In the next series of experiments, we tested the ORF3, gI and
ORF28/29 promoters in reporter gene assays. IE62 activated all of
these reporters, while Sp1, Sp3 and Sp4 activated signiﬁcantly
ORF3 and gI promoters, as shown in Fig. 2. Sp1 overexpression
activated ORF3 and gI promoter 4- and 8-fold respectively while
Sp3 overexpression activated the two promoters 7- and 11-fold
respectively. Also, Sp4 ectopic expression activated ORF3 and gI
Table 1
List of the VZV promoters that contain predicted Sp1 binding site(s).
VZV gene No. of Sp1 sites Sp1 site sequence
ORF3 1 CCCGCCC
ORF4 1 CCGCC
ORF6 2 GGAGCCGCCC
CCGCC
ORF10 1 CGGCGGG
ORF13 1 GGCGG
ORF18 1 GGAGGCGGG
ORF23 1 GCACCGCCCC
ORF25 1 CGGCGG
ORF28&29 1 CCCCACGCCC
ORF32 1 CCGCACCCG
ORF33 4 GGCGGCG
CGGCGGC
CGGCGG
GCCGCCC
ORF35 1 CCGCCGCCG
ORF37 2 CCCGCC
GCCGCC
ORF38&39 1 GGCGGGG
ORF40 2 CCGCCCCCG
CCCGCAC
ORF41 1 CCACGCCC
ORF44 1 CCCGGGCGGC
ORF45 1 CCGCC
ORF46 1 CCGCC
ORF50 1 CGCCGCCG
ORF51 2 GAGGCGGC
CCGCACCC
ORF52 1 CGGGGCGG
ORF56 1 CGGCGG
ORF61 1 GGCGG
ORF62 & ORF71 1 CGAGGCGGG
ORF63 & ORF70 1 CTCCCGCCCCGG
ORF64 1 CCGCCCCCCC
ORF65&66 1 CTCCGCCCTC
ORF67 1 CACGCCCC
ORF68 1 GGGCGGGG
ORF69 1 GGGGGGGCGG
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promoters 8- and 13-fold respectively. Ectopic expression of both
Sp3 and Sp4 enhanced IE62-mediated transactivation of ORF3 and
gI promoters by 6 fold and 2 fold respectively (Fig. 2A and B).
However, Sp2 overexpression reduced IE62 activation of the gI
promoter by about 50% but not the ORF3 promoter, while Sp1 had
no statistically signiﬁcant effect on IE62 activation of either of
Fig. 1. The inﬂuence of ectopic expression of Sp1, Sp2, Sp3 and Sp4 on IE62 mediated transactivation of model promoters. (A) Schematic of the model promoters and
sequences of the consensus TATA element and the Sp1 site in the downstream region of VZV oriS. Results of triplicate transient transfection assays determining the effect of
Sp family members' overexpression on IE62 mediated transactivation are shown for (B) the TA-Luc model promoter and (C) the Sp1-TA-Luc model promoter. Luciferase
activities in the absence of IE62 and ectopic expression of Sp family members were normalized to one. Promoter activities in the presence of IE62 and ectopic expression of
Sp1, Sp2, Sp3, Sp4 or both are reported as induction (n-fold) of the luciferase activity over the basal activity. Statistical signiﬁcance was determined by a one-way ANOVA
analysis of variance followed by Tukey's posthoc test. Error bars indicate standard error.
Fig. 2. The inﬂuence of ectopic expression of Sp1, Sp2, Sp3 and Sp4 on IE62 mediated transactivation of selected VZV promoters. Results from triplicate transient transfection
assays showing the effect of the Sp family members on IE62 mediated transactivation are presented with (A) ORF3 promoter, (B) gI promoter. Luciferase activities in the
absence of IE62 and ectopic expression of Sp family members were normalized to one. Promoter activities resulting from the presence of IE62 and the ectopic expression of
Sp1, Sp2, Sp3, Sp4 or both are reported as induction (n-fold) of the luciferase activity over the basal activity. Statistical signiﬁcance was determined by a one-way ANOVA
analysis of variance followed by Tukey's posthoc test. Error bars indicate standard error.
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these two promoters. Interestingly, only Sp3 reduced signiﬁcantly
IE62-mediated transactivation of the ORF28/29 promoter by about
50% (Fig. 3A and B). In contrast, the inhibition of the IE62
activation of the ORF28/29 promoter by Sp2 and Sp4 overexpres-
sion was statistically insigniﬁcant.
The increase in the expression levels of Sp family members in
the overexpression experiments was determined using western
blot analysis and was shown to be 2-fold (Fig. 4).
Sp family members interact physically with the IE62 acidic activation
domain, and deletion of IE62 aa 238–258 affects the interaction, as
well as IE62 mediated transactivation
A physical interaction has been demonstrated between Sp1 and
IE62, and has been suggested to be part of the mechanism of joint
Sp1-IE62 activation of VZV promoters (Peng et al., 2003). Based on
our ﬁndings above, we next determined if there were physical
interactions between IE62 and the other Sp family members Sp2,
Sp3 and Sp4. Prior work had shown that Sp1 is capable of binding
to IE62 in the absence of other viral proteins (Peng et al., 2003),
and amino acids 226–299 of IE62 were necessary for the interac-
tion with Sp1 in protein pull-down experiments.
GST-IE62 fusion proteins containing N-terminal fragments of
IE62 used to show this interaction (Fig. 5A), including GST-IE62 (1–
226), GST-IE62 (1–299), and GST-IE62 (1–299)d20 [in which amino
acids 238–258 are deleted] were tested in screens utilizing VZV-
infected MeWo cell nuclear extracts. These experiments showed
that Sp3 and Sp4 bound to IE62 (1–299) and not IE62 (1–226). In
addition, we narrowed down the binding region for all three
factors to IE62 (238–258) (Fig. 5B). In contrast, Sp2 bound to IE62
(1–226).
Next, we examined the inﬂuence of the deletion of amino acids
238–258 on IE62 transcriptional activation. In this set of experi-
ments, reporter gene assays were done in the context of transfec-
tion of either wild type pCMV-62 or pCMV-62 with a deletion of
amino acids 238–258. We used the model reporters, pTA-Luc and
pSp1-TA-Luc, as well as the ORF3-Luc, gI-Luc and R28/29F repor-
ters. Luciferase activities obtained from each reporter plasmid in
the absence of ORF62 transfection represented the basal level for
the plasmid and were normalized to 1. Reporter gene activities in
the presence of ORF62 transfection were reported as induction (n-
fold) of luciferase activities relative to the basal activity. The
deletion of amino acids 238–258 reduced IE62-mediated transac-
tivation of ORF28/29 and pTA-Luc promoters signiﬁcantly but had
no inﬂuence on ORF3-Luc, gI-Luc and pSp1-TA-Luc, as shown in
Fig. 5C.
Sp1 and Sp3 bind to the predicted Sp1 binding site within the gI
promoter but not to the ORF28/29 promoter
In these experiments, we used EMSA and supershift assays to
establish the binding of the four Sp family members to predicted
binding sites within the gI and ORF28/29 promoters. Experiments
were done using 40 bp duplex oligonucleotides containing wild
type Sp1 sites within these promoters and nuclear extracts from
VZV infected MeWo cells (Fig. 6).
EMSA and supershift assays using oligonucleotides containing
the predicted Sp1 binding site from the gI promoter revealed
multiple complexes including two major faster-migrating com-
plexes and two minor slower-migrating complexes (Fig. 6B). Anti-
body supershift assays were then performed to assess the binding
of the Sp family members to this site. The anti-Sp1 antibody
supershifted one of the major complexes while anti-Sp3 antibody
supershifted the other major complex (Fig. 6B).
Next, a similar series of experiments was done to detect the
binding of Sp family members to the ORF28/29 promoter. Again,
numerous complexes were formed using the Sp1 site containing
oligonucleotides from the ORF28/29 promoter (Fig. 6C). Antibody
supershift assays were then performed to determine the binding
of the Sp1, 2, 3 and 4 cellular transcription factors to these
sequences. No supershifted band was detected in the presence of
any of the four antibodies.
Fig. 3. The inﬂuence of ectopic expression of Sp1, Sp2, Sp3 and Sp4 on IE62 mediated transactivation of selected VZV promoters. Results from triplicate transient transfection
assays showing the effect of the Sp family members on IE62 mediated transactivation are presented with (A) ORF28 promoter, (B) ORF29 promoter. Luciferase activities in the
absence of IE62 and ectopic expression of Sp family members were normalized to one. Promoter activities resulting from the presence of IE62 and the ectopic expression of
Sp1, Sp2, Sp3, Sp4 or both are reported as induction (n-fold) of the luciferase activity over the basal activity. Statistical signiﬁcance was determined by a one-way ANOVA
analysis of variance followed by Tukey's posthoc test. Error bars indicate standard error.
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Fig. 4. Western blot analysis examining the levels of (A) Sp1, (B) Sp2, (C) Sp3 and (D) Sp4 in mock transfected and overexpression whole cell lysates of MeWo cells. Equal
amounts of protein were added in each lane. β-tubulin was used as a loading control.
Fig. 5. The role of IE62 amino acids 238–258 in interaction with Sp family members and IE62-mediated transactivation. (A) A schematic diagram shows the IE62 truncations
used in the GST pull-down experiment and viral and cellular protein interactions-with these truncations. (B) GST pull-down analyses of the region of IE62 that interacts with
the cellular transcription factors, Sp1, Sp2, Sp3 and Sp4. Truncated GST-tagged IE62 proteins were coupled to glutathione-Sepharose beads and incubated with nuclear
extracts of VZV infected MeWo cells. GST alone was used as a control. The binding of Sp1, Sp2, Sp3 and Sp4 to the GST-IE62 fusions was examined by Western blotting (upper
panels). The lowest panel is a Coomassie blue stain showing the levels of the GST-tagged IE62 fusion proteins eluted from the glutathione beads. (C) Results of the triplicate
transient transfection assays determining the effect of the deletion of amino acids 238–258 of IE62 on IE62 mediated activation of the model and VZV promoters
studied above.
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Ectopically expressed Sp3 decreases the efﬁciency of VZV origin-
dependent DNA replication
In our previous work we established that Sp1 and Sp3 bound to
the downstream region of the VZV oriS (Khalil et al., 2008).
Mutation of their binding sites not only inhibited binding but also
suppressed VZV origin-dependent DNA replication in DpnI assays
(Khalil et al., 2012). We performed DpnI replication assays in the
presence of ectopically expressed Sp family members in order to
further examine the inﬂuence of these cellular transcription
factors on VZV DNA replication. These experiments involved co-
transfection of the pLitmus R62/63 F plasmid (Khalil et al., 2011,
2012) containing the VZV oriS sequence, with individual plasmids
expressing each of the Sp factors into MeWo cells, followed by VZV
superinfection at a ratio of 0.4/1 infected to uninfected cells.
In the ﬁrst series of experiments, triplicate DpnI assays were
done using wild type pLitmus R62/63F plasmid with and without
plasmids expressing Sp1, Sp2, Sp3 and Sp4. As shown in Fig. 7, only
Sp3 was associated with a highly signiﬁcant decrease in DNA
replication. Sp1, Sp2 and Sp4 had no signiﬁcant effects. The decrease
observed with Sp3 was consistent with this factor acting as a
repressor of ORF28 and ORF29 expression in reporter gene assays.
Discussion
All of the VZV promoters that have been examined to date are
activated by the major virus transactivator IE62, either with or
without a functional TATA box. There are at least two VZV
promoters (for ORF3 and ORF10) that are known to have no TATA
element (Khalil et al., 2013; Che et al., 2007). In contrast, all known
VZV promoters contain predicted or deﬁned binding sites for one
or more cellular transcription factors including ATF, USF, YY1 and
Sp1. The binding of these factors to the viral promoters inﬂuences
gene expression both in vitro and in vivo (Berarducci et al., 2007;
Che et al., 2007; Ito et al., 2003; Meier et al., 1994; Narayanan et al.,
2005; Peng et al., 2003; Rahaus and Wolff, 2003; Rahaus et al.,
2003; Wang et al., 2009; Yang et al., 2004; Khalil et al., 2013, 2014).
Nine Sp family members, Sp1-Sp9, belong to the Sp/KLF family
of transcription factors. These proteins bind with high afﬁnity to
GC-rich sequences (Suske, 1999). About half of the known or
putative VZV promoters contain GC boxes that could function as
Sp1 binding site, as shown in Table 1. Sp1 was the ﬁrst Sp family
member found to bind GC boxes in authentic VZV gene promoters,
including those for gI, ORF28/29, gE and ORF61 and was assumed
to be the major player in the Sp family for VZV.
Sp family members not only play an important role in VZV
replication but also in replication of other herpesviruses. In the
case of HSV-1, Sp1 and Sp3 are involved in the DNA replication
process (Nguyen-Huynh and Schaffer, 1998). Mutations of the Sp1/
Sp3 binding site in the HSV oriS decreased DNA replication
efﬁciency by approximately 60%. Also, Sp1 binds to HSV promo-
ters, including those for ICP-4, thymidine kinase, UL19, ICP34.5 and
UL50, and is required for promoter activation (Jones et al., 1985;
Jones and Tjian, 1985; Huang and Wagner, 1994; Chung et al.,
1995; Pande et al., 1998). In the case of HCMV, Sp1 binds to the
DNA polymerase (UL54) promoter and is required for the activa-
tion of this promoter by HCMV immediate early proteins IE72 and
IE86 (Luu and Flores, 1997). Moreover, there are two Sp1/Sp3
binding sites identiﬁed within the major immediate early (MIE)
promoter of HCMV, and mutation of these sites inhibits transcrip-
tion from this promoter (Isomura et al., 2005). In EBV, Sp1 and Sp3
interacts with the viral DNA polymerase and its processivity factor
to stimulate DNA replication (Baumann et al., 1999; Gruffat et al.,
Fig. 6. EMSA and supershift assays using 40 bp oligonucleotides containing the wild-type Sp1 site of the gI promoter or the ORF28/29 promoter. (A) Sequences of the two
oligonucleotides used in the assays. The Sp1 sites appear in bold underlined. (B) EMSA and supershift assays using a 40 bp gI probe and (C) EMSA and supershift assays using
a 40 bp ORF28/29 probe. Supershift assays were done in the presence of VZV-infected cell nuclear extracts using polyclonal antibodies against Sp1, Sp2, Sp3 and Sp4. Lanes:
FO, free oligonucleotide; I, VZV-infected nuclear extract. The positions of the original complexes are indicated by arrows and the positions of the supershifted bands are
indicated by asterisks.
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1995). Sp1 and Sp3 have been shown to bind to BRLF1 and ED-L1E
promoters and binding site mutations inhibited activation of these
promoters (Ragoczy and Miller, 2001; Tsai et al., 1999).
In this study, we expanded our previous investigation of the
role of Sp family members in VZV IE62-mediated transactivation,
by determining the inﬂuence of ectopic overexpression of Sp1–4
on transcriptional activation of IE62 with model and VZV promo-
ters containing GC-rich boxes. First, we identiﬁed the binding of
Sp3 to the GC box of the gI promoter, which had been shown
previously to be an Sp1-binding site. No binding of Sp2 and Sp4 to
this sequence was observed. These results are similar to those
described earlier with the ORF3 promoter and the downstream
region of the VZV oriS. They also imply the need to retest all of the
previously studied GC boxes in VZV promoters for the binding of
other Sp family members.
Yang et al. (2004) demonstrated binding of Sp1 to the 221 bp
intergenic region between ORF28 and 29, which includes the
promoter elements of both genes, using magnetic bead recruit-
ment assays. However, no other Sp family member was tested in
these experiments. Mutation of the GC box (the same one that we
tested in our EMSA and supershift assays for the binding of Sp
family members) in the magnetic bead recruitment assay inhibited
the interaction of Sp1 with this 221 bp sequence. Interestingly,
none of the Sp family members tested bound to the GC box of the
ORF28/29 promoter using EMSA and supershift assays under our
experimental conditions. These results do not exclude completely
the possibility of the binding of Sp1 (and probably other Sp family
members) to the ORF28/29 promoter as shown in magnetic bead
recruitment assays. The size of the duplex oligonucleotides used in
the EMSA and supershift assays is 40 bp, which is short compared
to the size of the probe (221 bp) used in the magnetic bead
recruitment assays. This difference may affect the binding that
might result from cooperative interaction of the Sp family mem-
bers and the promoter, as shown by Yang et al. (2004).
Most surprisingly, ectopic overexpression of Sp1 had no effect
on IE62 transactivation of any of the model or VZV promoters that
we studied. In contrast, the overexpression of Sp3 enhanced both
IE62-mediated transactivation of the model promoter containing
the Sp1 site from the downstream region of VZV oriS, as well as
VZV promoters that contained functional GC boxes (e.g. ORF3 and
gI). Also, the ectopic expression of Sp3 reduced IE62 activation of
the ORF28/29 promoters that do not contain a functional GC box.
This all suggests that the positive inﬂuence of Sp3 on IE62
transcriptional activation is due to the binding of Sp3 to the
promoter. These results also indicate that although Sp1 binds to
all of the VZV promoters that contain GC boxes and physically
interacts with IE62, it has no obvious role in IE62-mediated
transactivation, at least with the promoters we have studied. This
implies that the effects seen on activation of promoters following
mutation of the GC rich element (e.g. ORF61, gE, Berarducci et al.,
2007 and Wang et al., 2009) are probably due to the binding of Sp3
rather than Sp1.
Sp1 and Sp3 are ubiquitously expressed in cell types and tissues
that support VZV lytic replication but are present at low levels in
neuronal cells and tissues where the virus is able to establish
latency. About half of the 71 VZV promoters contain putative Sp
family binding sites and Sp3 overexpression clearly shows sub-
stantial IE62 activation of the VZV promoters that contain func-
tional GC boxes. This might explain why VZV gene expression is
upregulated during lytic infection in tissues expressing Sp3 (and
Sp1) at a high level, while it is down-regulated during latency in
neuronal tissues that express both at only low levels.
Fig. 7. The effect of the ectopic expression of the cellular transcription factors Sp1, Sp2, Sp3 and Sp4 on origin dependent DNA replication from the wild type pLitmus R62/
63F plasmid containing the VZV oriS. (A) Typical southern blot analysis of the effects of the ectopic expression of Sp family members on oriS-dependent DNA replication. The
upper band (R) indicates the position of DpnI resistant DNA resulting from replication within the MeWo cells. The lower band (U) indicates the position of unreplicated input
plasmid. (B) Histogram summarizing the data from three independent DpnI replication assays. Statistical signiﬁcance was determined by a one-way ANOVA analysis of
variance followed by Tukey's posthoc test. Error bars indicate standard error.
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The ectopic expression of Sp4 enhanced IE62 activation of gI and
ORF3 promoters but the level was less thanwith Sp3. Sp4 is expressed
in several cell lines at a level less than that of Sp1, Sp2 and Sp3, but is
expressed more abundantly than other Sp family member in cells of
neuronal origin (Lerner et al., 2005). Thus, it might play an important
role in the reactivation of VZV from latency in these tissues by
enhancing IE62-activation of VZV promoters. The overexpression of
Sp2 displayed a negative inﬂuence over IE62-mediated transactivation
of the model promoters and the gI promoter, which reﬂects the
general transcriptional inhibitory inﬂuence of Sp2.
The inhibition by Sp3 of oriS-dependent DNA replication in the
DpnI assays seems likely to be an indirect effect of Sp3 on IE62-
mediated transactivation of the ORF28/29 promoter. We know
from our prior work that mutation of the Sp1/Sp3 site in the
downstream region of VZV oriS inhibits oriS-dependent DNA
replication in MeWo cells (Khalil et al., 2012).
Sp2, Sp3 and Sp4 bind to domain I of IE62, as does Sp1. The
amino acids 238–258 of IE62 are important for the physical inter-
action of Sp3 and Sp4 with IE62, but Sp2 binds to a different region
of IE62 (amino acids 1–226) which includes the N-terminal acidic
activation domain. The deletion of amino acids 238–258 of IE62
reduced signiﬁcantly the activation by IE62 of the promoters that
lack functional GC boxes (like the TA-Luc and ORF28/29 promoters)
but had no effect on the promoters with a functional GC-rich
element, such as the ORF3 and gI promoters and Sp1-TA-Luc. This
latter effect may be due to the ability of Sp1 and Sp3 to bind to these
promoters and to their ability to aid in the stabilization of the
transcription complex in the absence of a physical interaction
between IE62 and Sp1 and/or Sp3. On the other hand, with the
TA-Luc and ORF28/29 promoters there is no binding of Sp1 or Sp3
and thus no physical interaction between IE62 and these two
proteins, which could also inﬂuence the stabilization of the tran-
scription complex. All the data on the Sp family members' interac-
tions with IE62 and VZV promoters, as well as their inﬂuence on
IE62-mediated transactivation are summarized in Table 2.
Sp family members, Sp1–4, have been shown to play important
roles during differentiation and development of human cells, as well
as in cell cycle regulation. Sp1, Sp3 and Sp4 interact with several
proteins involved in cell cycle regulation, such as E2F family
members and retinoblastoma-like proteins (Rb and P130), as well
as interacting with each other (e.g, Sp1 binds to both Sp3 and Sp4)
(Karlseder et al., 1996; Rotheneder et al., 1999; Chang et al., 2001;
Zhang et al., 2003). Thus the possibility exists that part of the ability
of these factors (speciﬁcally Sp3 and Sp4) to enhance IE62-mediated
transactivation may be due to their ability to recruit additional
cellular factors involved in transcriptional activation.
The results of this study suggest that, at least in MeWo cells,
Sp3, rather than Sp1, may act as a major player in IE62-mediated
transactivation of the VZV promoters containing a functional GC-
rich sequence. Applying this idea to other VZV promoters that
have been shown to contain functional GC-rich sequences (e.g.
ORF61 and gE) will help in understanding this possible new role
for Sp3 in VZV replication. The same may be true for other
herpesviruses; for example, looking at binding of Sp1 and Sp3 to
HSV oriS and EBV oriLyt, may open the door to investigating which
of them (or both) inﬂuences herpesvirus replication in general.
The further study of cellular transcription factors affecting VZV
replication is essential for a better understanding of how the lytic
and latent stages of virus replication are controlled. In this study,
we have established the importance of the Sp family members, in
particular Sp3, in mediating VZV IE62 transcriptional activation,
and in controlling viral replication.
Materials and methods
Cells and viruses
MeWo cells, a human melanoma cell line was grown in Eagle's
minimal essential medium supplemented with 10% fetal bovine serum
(Spengler et al., 2000). VZV strain MSP was propagated in MeWo cell
monolayers as described by Lynch et al. (2002) and Peng et al. (2003).
Whole cell lysate and nuclear extract preparation
Whole cell lysates of mock transfected or overexpressing
MeWo cells were prepared in lysis buffer, 50 mM Tris–HCl, pH
7.5, 0.15 M NaCl, 1 mM EDTA, 0.1% Triton X-100 and protease
inhibitor cocktail (Roche, Mannheim, GE, added per the manufac-
turer's instructions) and analyzed for Sp1, Sp2, Sp3, and Sp4
expression by immunoblot as previously described (Khalil et al.,
2008). Antibodies against Sp1, Sp2, Sp3, Sp4, and β-tubulin were
obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Quanti-
ﬁcation of the relative amounts of these transcription factors
normalized to β-tubulin in loading controls was performed using
a Bio-Rad GS700 imagining densitometer (Bio-Rad, Hercules, CA).
Statistical signiﬁcance was determined by a one-way analysis of
variance, followed by Tukey's posthoc test.
Nuclear extracts of VZV infected MeWo cells were prepared as
previously described (Lynch et al., 2002). Cells were incubated in
buffer A (10 mM HEPES, pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM
dithiothreitol) at 4 1C for 15 min to lyse the cells and release the
cytoplasmic fraction. After centrifugation, the crude nuclear pellet
was incubated on ice in buffer C (20 mM HEPES, pH 7.9, 25% (v/v)
glycerol, 0.42 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM phe-
nylmethylsulfonyl ﬂuoride, 0.5 mM dithiothreitol). After centrifuga-
tion, the nuclear extract was dialyzed against buffer D (20 mM
HEPES, pH 7.9, 20% (v/v) glycerol, 0.1 M KCl, 0.2 mM EDTA, 0.5 mM
phenylmethylsulfonyl ﬂuoride, 0.5 mM dithiothreitol).
Table 2
Summary of the Sp family members' activities and interactions.
Sp1 Sp2 Sp3 Sp4
IE62 interaction þ þ þ þ
IE62 (238–258) IE62 (1–226) IE62 (238–258) IE62 (238–258)
DNA replication ns ns   ns
ORF28/29 promoter ns ns   ns
ORF3 promoter ns ns þþþ þ
gI promoter ns   þþþ þ
TA-Luc ns   ns –
Sp1-TA-Luc ns   þþ ns
gI promoter binding þ  þ –
(þ) Means increasing or interacting, (–) means inhibiting, (ns) means non-signiﬁcant inﬂuence.
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Plasmids
Luciferase reporter plasmids containing the ORF3, ORF28/29
and gI promoters were constructed as described (Khalil et al.,
2013; Yang et al., 2004; White et al., 2010). Wild type ORF3-Luc
was constructed by inserting a 340 bp intergenic region between
ORF3 and ORF4 into the pGL2 basic vector, ﬂanked by ﬁreﬂy
luciferase. Wild type R28/29F was constructed by inserting a
221 bp intergenic region between ORF28 and ORF29 into the basic
pGL2 luciferase vector containing the Renilla and ﬁreﬂy luciferase
reporters. Wild type gI-Luc was constructed by inserting the gI
(VZV ORF67) promoter sequence into the pGL2 basic vector,
ﬂanked by ﬁreﬂy luciferase.
A chimeric pTA-Luc vector was constructed as described in Yang
et al. (2006) based on the pGL-2 basic vector (Promega, Madison,
WI). The TATA element and ﬂanking sequences derived from the
adenovirus major late promoter were inserted between the XhoI
and HindIII sites of the pGL-2 vector to generate the pTA-Luc
minimal reporter vector. The pSp1-TA-Luc plasmid was generated
by insertion of the Sp1 consensus site (5-GGGGTGTGGGCGGGC-3)
from the downstream region of VZV oriS, into the pTA-Luc vector,
25 bp upstream of the TATA box, using the QuikChange Site-Directed
Mutagenesis Kit (Stratagene). The primers used for insertion of the
Sp1 site were: 50 GGGGAGGTACCAGCTGGGGTGTGGGCGGGCCT
TACGCGTGCTAG-30 and 50–CTAGCACGCGTAAGAGCCCGCCCA-
CACCCCGCTCG GTACCTCCCC-30.
A pCMV62 plasmid expressing ORF62 under the control of the
cytomegalovirus immediate-early (IE) promoter has been described
previously (Perera et al., 1992, 1993). The pCMV62-d20 was derived
from pCMV62 by site-directed mutagenesis using the QuikChange
site-directed mutagenesis kit (Stratagene, Cedar Creek, TX) to delete
20 amino acids (238–258) in the ORF62 gene. The pCMV-Sp1,
pCMV-Sp2, pCMV-Sp3 and pCMV-Sp4 expressing plasmids were
purchased from Origene Technologies (Rockville, MD).
The p-Litmus R62/63F plasmid containing the wild type 1.5 kb
region of DNA between ORF62 and ORF63 was constructed as
described by Jones et al. (2006). It contains the complete sequence
between the ORF62 and ORF63 genes including the VZV OriS
structure cloned in an orientation between genes encoding the
Renilla and ﬁreﬂy luciferases (Promega) so that the luciferase
genes acted as reporters of ORF62 and ORF63 transcription
respectively.
The pGEX-IE62 series was constructed as previously described
by Peng et al. (2003) and Spengler et al. (2000), using the pGEX-
4T-3 plasmid (Amersham Biosciences, Piscataway, NJ) to encode
the N-terminal portions of the VZV ORF62 protein with an N-
terminal GST tag. These were pGEX-IE62 (1–226) and pGEX-IE62
(1–299) and were generated by inserting each of the respective
ORF62 coding sequences between the BamHI and SalI sites in the
pGEX-4T-3 vector. The pGEX-IE62 (1–299d20) was derived from
pGEX-IE62 (1–299) by site-directed mutagenesis using the Quik-
Change site-directed mutagenesis kit (Stratagene, Cedar Creek, TX)
to delete 20 amino acids (238–258) in the ORF62 gene.
Reporter gene assays
Luciferase reporter gene assays were performed in MeWo cells
as previously described (Yang et al., 2004). Transfections were
performed using 12-well plates. 2105 MeWo cells were seeded
in each well 24 h before transfection. Cells were transfected with
one microgram of each reporter vector using Lipofectamine
reagent (Invitrogen, Carlsbad, CA), along with 5 ng of pEF1α-RL
plasmid (Promega, Madison, WI) for Sp1-TA-Luc, TA-Luc, ORF3 and
gI promoter experiments or 0.4 μg of β-galactosidase (β-Gal)-
expressing plasmid (Invitrogen, Carlsbad, CA) for ORF28/29 pro-
moter experiments, as controls of transfection efﬁciency. The
reporter plasmids were also co-transfected using 5 ng of wild type
or d20 pCMV-ORF62 expressing plasmids and 0.6 mg of pCMV-Sp1,
pCMV-Sp2, pCMV-Sp3 and pCMV-Sp4. Dual luciferase activities
were normalized to Renilla luciferase activities or β-Gal. pcDNA
was transfected along with the pCMV62 plasmids to equalize the
amounts of both total DNA and the promoter constructs in each set
of transfections.
Cells were lysed 48 h posttransfection or super-infection in
250 μl of lysis buffer (50 mM HEPES, pH 7.4, 250 mM NaCl, 1% NP-
40, 1 mM EDTA). Control experiments without transfection of
pCMV-ORF62 were carried out for each plasmid to determine
basal expression levels. Dual-luciferase assays were performed
according to the manufacturer's instructions. Transfection experi-
ments were repeated at least three times.
EMSA and supershift analyses
40 bp oligonucleotide probes (IDT, Coralville, IA) containing the
Sp1 site of the gI or ORF28/29 promoters were used in electro-
phoretic mobility shift assays (EMSAs). Probes were end-labeled
with ATP [α-32P] using T4 kinase (Invitrogen, Carlsbad, CA). One
hundred femtomoles of the labeled probes (1105 dpm) were
incubated with 15 mg of VZV infected MeWo cell nuclear extract in
a 10 ml reaction mixture in binding buffer: 40 mM HEPES, pH 7.9,
100 mM NaCl, 10 mM MgCl2, 200 mg/ml bovine serum albumin
(BSA), 12% glycerol, 0.05% NP-40, 1 mM dithiothreitol, and 3 mg
poly (dI.dC). In the supershift assays, rabbit polyclonal anti-Sp2,
Sp3 and Sp4 antibodies obtained from Santa Cruz Biologicals
(Santa Cruz, CA) or anti-Sp1 antibodies (Upstate, Temecula, CA)
were added in 4 mg aliquots to reaction mixtures before the
addition of the labeled probe to the nuclear extract-antibody
mixture. The samples were analyzed by electrophoresis on a 5%
polyacrylamide (37.5:1 acrylamide/bisacrylamide) gel followed by
autoradiography.
DpnI replication assays
MeWo cells were transfected with Lipofectamine reagent
(Invitrogen, Carlsbad, CA) according to the manufacturer's instruc-
tions. 4 μl of Lipofectamine reagent was used per μg of transfected
DNA in each transfection. Transfections were performed in 100-
mm-diameter dishes, with 2.106 MeWo cells per dish seeded in
12 ml of complete growth medium. The medium was replaced
three hours before transfection and cells were 80% conﬂuent at the
time of transfection. Origin-dependent DNA replication experi-
ments were performed as described previously (Khalil et al.,
2008). In the ectopic expression experiments 6 mg of pCMV-Sp1,
pCMV-Sp2, pCMV-Sp3 or pCMV-Sp4-expressing plasmids were
transfected in the presence of 5 μg of wild type pLitmus R62/63F
plasmid. At 6 h post-transfection, cells were superinfected with
VZV strain MSP by adding a ratio of 0.4 infected cells per
1 uninfected cell to each monolayer. 6 mg of the empty cloning
vector, pcDNA, were transfected along with the plasmids ectopi-
cally expressing the cellular transcription factors to equalize the
amount of both total DNA and CMV promoter in each set of
transfections. Total cellular DNA was prepared 48 h after super-
infection, and the DNA was isolated by phenol–chloroform extrac-
tion followed by ethanol precipitation. The DNA was digested with
DpnI and EcoRI (Stow and Davison, 1986), and analyzed by
Southern blot hybridization. The blots were probed with a 476-
bp PCR product prepared from pLitmus R62/63F by using primers
5 blot hybridization. The blots were probed with a 476-bp PCR
product prepared from pLitmusigin of DNA α-32P] ATP by using T4
kinase (Invitrogen, Carlsbad, CA).
The resulting bands were quantiﬁed by PhosphorImager (Mole-
cular Dynamics, Sunnyvale, CA) analysis. The ratio of replicated
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plasmid to input plasmid represents the replication efﬁciency of
the test plasmid. The data from representative experiments are
presented as means of results from triplicate DpnI replication
assays. Statistical signiﬁcance was determined by a one-way
ANOVA followed by Tukey's posthoc test.
GST-tag protein afﬁnity pull-down assays
Following induction with IPTG, crude lysates of Escherichia coli
expressing GST and GST-IE62 fusions were prepared and clariﬁed
as previously described (Peng et al., 2003). Two hundred microliter
aliquots of the bacterial lysates were added to 50 ml glutathione-
Sepharose beads and incubated for 1 h at 4 1C. Then 250 mg of VZV
infected MeWo cells nuclear extracts in 250 ml buffer D was added
to the protein-coupled beads. Incubation was performed for 3 h at
4 1C and followed by repeated washings with 0.1% Triton X-100 in
buffer D; bound protein was eluted with 80 ml 2 SDS-PAGE
sample buffer by boiling for 5 min and then analyzed by SDS-PAGE
and immunoblotting.
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